Fresenius Medical Care AG (FMS) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $4.3 billion.
- Fresenius Medical Care AG's Cost of Revenue rose 729.11% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 billion, marking a year-over-year increase of 419.17%. This contributed to the annual value of $15.6 billion for FY2024, which is 34.08% down from last year.
- Latest data reveals that Fresenius Medical Care AG reported Cost of Revenue of $4.3 billion as of Q3 2025, which was up 729.11% from $4.0 billion recorded in Q2 2025.
- In the past 5 years, Fresenius Medical Care AG's Cost of Revenue ranged from a high of $4.3 billion in Q3 2025 and a low of $3.6 billion during Q1 2021
- In the last 5 years, Fresenius Medical Care AG's Cost of Revenue had a median value of $3.9 billion in 2024 and averaged $3.9 billion.
- In the last 5 years, Fresenius Medical Care AG's Cost of Revenue crashed by 221.3% in 2022 and then soared by 729.11% in 2025.
- Fresenius Medical Care AG's Cost of Revenue (Quarter) stood at $3.8 billion in 2021, then dropped by 2.21% to $3.7 billion in 2022, then increased by 5.14% to $3.9 billion in 2023, then grew by 4.12% to $4.1 billion in 2024, then increased by 4.49% to $4.3 billion in 2025.
- Its Cost of Revenue stands at $4.3 billion for Q3 2025, versus $4.0 billion for Q2 2025 and $3.9 billion for Q1 2025.